Contribution of endothelin-1 to disruption of blood-brain barrier permeability in dogs

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 360, Issue 6, 1999, Pages 639-645

  Narushima, Itaru ^a   Kita, Taizo ^a   Kubo, Kaoru ^a   Yonetani, Yukio ^a   Momochi, Chika ^a   Yoshikawa, Ichigo ^a   Shimada, Keiji ^a   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Endothelin ET(A) receptor antagonist; Endothelin 1; Subarachnoid hemorrhage; Two hemorrhage model

Indexed keywords

27 O 3 [2 (3 CARBOXYACRYLOYLAMINO) 5 HYDROXYPHENYL]ACRYLOYLOXY MYRICERONE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CEREBROVASCULAR MALFORMATION; CONTROLLED STUDY; DOG; DRUG EFFECT; NEUROPATHOLOGY; NONHUMAN; SUBARACHNOID HEMORRHAGE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD; BLOOD-BRAIN BARRIER; CAFFEIC ACIDS; CELL MEMBRANE PERMEABILITY; CISTERNA MAGNA; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; FLUORESCEIN; INJECTIONS, INTRAVENTRICULAR; MALE; OLEANOLIC ACID; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SUBARACHNOID HEMORRHAGE;

EID: 0033394418     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900137     Document Type: Article

References (20)

1. Asano T, Ikegami I, Satoh S, Suzuki Y, Shibuya M, Sugita K, Hidaka H (1990) Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmol 190:365-372
2. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834
3. Dehouck MP, Vigne P, Torpier G, Breittmayer JP, Cecchelli R, Frelin C (1997) Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab 17:464-469
4. Dóczi T, Joó F, Ádám G, Bozóky B, Szerdahelyi P (1986) Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model. Neurosurgery 18:733-739
5. Ehrenreich H, Lange M, Near KA, Anneser F, Schoeller LAC, Schmid R, Winkler PA, Kehrl JH, Schmiedek P, Goebel FD (1992) Long-term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med 192:257-268
6. Gulati A, Nath C, Shanker K, Dhawan KN, Bhargava KP (1982) Fluorescein spectrophotofluorometry: a sensitive quantitative method for evaluating the blood-brain barrier. Pharmacol Res Commun 14:649-661
7. Joshita H, Kassell NF, Sasaki T (1990) Blood-brain barrier disturbance following subarachnoid hemorrhage in rabbits. Stroke 21:1051-1058
8. Kim CJ, Bassiouny M, Macdonald RL, Weir B, Johns LM (1996) Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Stroke 27:1629-1633
9. Kita T, Kubo K, Hiramastu K, Sakaki T, Yonetani Y, Sato S, Fujimoto M, Nakashima T (1998) Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model. Life Sci 63:305-315
10. Kraus GE, Bucholz RD, Yoon KW, Knuepfer MM, Smith KR Jr (1991) Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review. Surg Neurol 35:20-29
11. Macdonald RL, Weir BKA (1991) A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982
12. Mihara S, Nakajima S, Matumura S, Kohnoike T, Fujimoto M (1994) Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139. J Pharmacol Exp Ther 268:1122-1128
13. Miller RD, Monsul NT, Vender JR, Lehmann JC (1996) NMDA-and endothelin-1-induced increases in blood-brain barrier permeability quantitated with lucifer yellow. J Neurol Sci 136: 37-40
14. Ohlstein EH, Storer BL (1992) Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77:274-278
15. Pardridge WM (1998) CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70:1781-1792
16. Roux S, Löffler BM, Gray GA, Sprecher U, Clozel M, Clozel JP (1995) The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37:78-86
17. A-receptor antagonist, S-0139, on cerebral vasospasm and behavioral changes in dogs intracisternally administered endothelin-1. Life Sci 62:PL191-PL197
18. Shigeno T, Fritschka E, Brock M, Schramm J, Shigeno S, Cervós-Navarro J (1982) Cerebral edema following experimental subarachnoid hemorrhage. Stroke 13:368-379
19. 51Cr from cultured human cerebromicrovascular endothelium. Biochem Biophys Res Commun 191:1-8
20. Suzuki H, Sato S, Suzuki Y, Oka M, Tsuchiya T, Iino I, Yamanaka T, Ishihara N, Shimoda S (1990) Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage. Ann Med 22:233-236